Ebrahimi, E., and R. Shirkoohi. “What Is the Best Risk-Reducing Decision for Breast Cancer Patients With BRCA1/2 Mutation?”. Archives of Breast Cancer, Nov. 2018, pp. 148-9, doi:10.32768/abc.201854148-149.